Skip to main content
. 2022 Sep 21;12:900010. doi: 10.3389/fonc.2022.900010

Figure 7.

Figure 7

The mean JOA scores of the knee (A) and ankle (B). The mean JOA scores of the knee were 85.38 ± 3.12 (mean ± SE) in group Z (n=13) and 83.38 ± 2.33 (mean ± SE) in group P (n=13) at base line. The mean JOA scores of the knee in group Z were 91.15 ± 2.78 (mean ± SE) at 24 weeks and 93.75 ± 2.23 (mean ± SE) at 48 weeks. There was a significant difference between the values at baseline and 48 weeks (p=0.027). The mean JOA scores of the knee in group P were 85.75 ± 2.21 (mean ± SE) at 24 weeks and 85.0 ± 2.38 (mean ± SE) at 48 weeks. There was significant difference between the values at 48 weeks of group P and Z (p=0.014) (A). The mean JOA scores of the ankle were 83.63 ± 4.29 (mean ± SE) in group Z (n=8) and 83.00 ± 5.40 (mean ± SE) in group P (n=7) at baseline. The mean JOA scores of the ankle in group Z were 85.88 ± 3.51 (mean ± SE) at 24 weeks and 91.67 ± 3.35 (mean ± SE) at 48 weeks. The mean JOA scores of the ankle in group P were 88.43 ± 3.70 (mean ± SE) at 24 weeks and 88.71 ± 3.64 (mean ± SE) at 48 weeks. There was no significant difference between each values (B). JOA, Japanese Orthopedic Association; SE, standard error; group Z, zaltoprofen group; group P, placebo group.